News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kamada Ltd. (KMDA.TA) Receives an Israeli Patent for its Ultrapure Transferrin for Pharmaceutical Compositions


3/9/2011 10:41:57 AM

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada, a biopharmaceutical company developing, manufacturing and marketing specialty life-saving therapeutics, announced today it has received an Israeli Patent for its Ultrapure Transferrin to be used in Pharmaceutical Compositions. This is the second patent issued to Kamada under the same title after being granted with the same patent title by the United States Patent Office (USPTO).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES